Wanru Yao, MA

Doctor
Haemophilia Comprehensive Care Center, Hematology Center, Beijing Key Laboratory of Pediatric Hematology Oncology; National Key Discipline of Pediatrics (Capital Medical University); Key Laboratory of Major Diseases in Children, Ministry of Education; Beijing Children’s Hospital, Capital Medical University, National Center for Children’s Health, China, 100045
Beijing, Beijing, China (People's Republic)

Wanru Yao, Hemophilia Comprehensive Care Center, Hematology Center, Beijing Children's Hospital, Capital Medical University, National Center of Children's Health, China. Major is haemophilia and coagulation diseases, has participated in many domestic and foreign trainings and lectures.Published many academic papers and was responsible for a number of international multi-center clinical trials

Presentation(s):

• PB0506 - Influence of F8 gene mutation on outcome in immune tolerance induction of hemophilia A children with inhibitors

  Monday, June 24, 2024
  13:45 – 14:45 ICT

• PB0621 - Population pharmacokinetics model of BAY81-8973 in Chinese children with severe haemophilia A

  Monday, June 24, 2024
  13:45 – 14:45 ICT

• PB0613 - Real-World Use of Emicizumab in Chinese Children with Hemophilia A: Retrospective Data from a Comprehensive Care Center

  Monday, June 24, 2024
  13:45 – 14:45 ICT

• PB1256 - Escalating low-dose individualized haemophilia prophylaxis: A focus in China at Dawn of a new era of cost effective Individualized prophylaxis

  Tuesday, June 25, 2024
  13:45 – 14:45 ICT